Updates in Newly Diagnosed and Relapsed/Refractory Multiple Myeloma from ASH 2021

Experts review key updates in multiple myeloma management from the ASH 2021 annual meeting.

February 4th 2022

Saad Usmani, MD, shares his excitement for additional clinical trial data in multiple myeloma presented at the ASH 2021 annual meeting.

February 4th 2022

Closing out his discussion on the ASH 2021 meeting, Saad Usmani, MD, shares key takeaways for clinical practice in multiple myeloma.